Repurposing propranolol as an antitumor agent in von Hippel-Lindau disease

OBJECTIVE: Von Hippel-Lindau disease (VHL) is a tumor predisposition syndrome characterized by CNS hemangioblastomas (HBs) and clear cell renal cell carcinomas (RCCs) due to hypoxia-inducible factor activation (pseudohypoxia). Because of the lack of effective medical therapies for VHL, HBs and RCCs...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Neurosurg
Päätekijät: Shepard, Matthew J., Bugarini, Alejandro, Edwards, Nancy A., Lu, Jie, Zhang, Qi, Wu, Tianxia, Zhuang, Zhengping, Chittiboina, Prashant
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7265978/
https://ncbi.nlm.nih.gov/pubmed/30497198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2018.5.JNS172879
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia